Relay Therapeutics Inc. Common Stock vs Southern Company — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B), while Southern Company trades at $86.05 (market cap $99.10B). The key difference: Southern Company is far larger — about 25.9× Relay Therapeutics Inc. Common Stock's market cap, and Southern Company pays a 3.53% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Southern Company for 12 Days on average.
| RLAY | SO | |
|---|---|---|
Market Cap | $3.82B | $99.10B |
Volume | 4,332,079 | 5,985,559 |
Sector | Health | Utilities |
52-Week High | $20.75 | $99.72 |
52-Week Low | $6.03 | $82.35 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $2.93B | $173.21B |
Dividend Yield | — | 3.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →